Topics

Human medicines European public assessment report (EPAR): Zyllt, clopidogrel, Peripheral Vascular Diseases,Stroke,Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 28/09/2009, Revision: 11, Status: Authorised

12:29 EDT 9 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Zyllt, clopidogrel, Peripheral Vascular Diseases,Stroke,Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 28/09/2009, Revision: 11, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Zyllt, clopidogrel, Peripheral Vascular Diseases,Stroke,Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 28/09/2009, Revision: 11, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zyllt, clopidogrel, Peripheral Vascular Diseases,Stroke,Acute Coronary Syndrome,Myocardial Infarction, Date of authorisation: 28/09/2009, Revision: 11, Status: Authorised"

Quick Search

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...